What peak expiratory flow (PEF) range defines the yellow zone on an asthma action plan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yellow Zone Peak Flow Range: 50-79% of Personal Best

The yellow zone on an asthma action plan should be defined as peak expiratory flow (PEF) between 50-79% of predicted or personal best 1. This is the standard established by the EPR-3 guidelines and represents the intermediate zone where patients need to increase monitoring and consider stepping up treatment.

Algorithmic Approach to Yellow Zone Definition

Primary Method: Percentage-Based Zones

  • Green Zone: PEF ≥80% of personal best (well-controlled)
  • Yellow Zone: PEF 50-79% of personal best (caution/increased symptoms)
  • Red Zone: PEF <50% of personal best (medical alert)

The EPR-3 guidelines specifically state that when PEF falls to 50-79%, patients should monitor their response to quick-relief medication carefully and consider contacting a clinician 1.

Clinical Context and Severity Classification

In the urgent/emergency care setting, the guidelines further clarify that:

  • Moderate exacerbations correspond to PEF 40-69% of predicted/personal best
  • Severe exacerbations show PEF <40% of predicted/personal best 1

This creates some overlap where the lower yellow zone (50-69%) aligns with moderate exacerbations requiring office or ED evaluation.

Important Caveats and Pitfalls

The "Gray Zone" Problem

Research acknowledges that the yellow zone criteria can be "ambiguous and often confusing to patients and physicians" 2. The 50-79% range is broad and may not capture early deterioration in all patients.

Individual Variability Matters

Studies show that patients in the same symptom category can have widely varying PEFR values 3. Some patients may have reduced sensitivity to dyspnea, meaning they don't perceive symptoms even when lung function declines significantly. For these high-risk patients, monitoring PEF variability when asymptomatic (coefficient of variation >8%) may identify those who need intervention before reaching traditional yellow zone thresholds 3.

Quality Control Analysis Alternative

Research suggests that individualized action points using quality-control analysis (PEF <3 standard deviations below patient's mean) can detect exacerbations earlier with 84% sensitivity and only 19% false-positive rate, compared to the conventional 60% threshold which had only 35% success rate 4. The 80% threshold performed better at 88% success rate 4.

Practical Implementation

For standard asthma action plans, use the 50-79% range as your yellow zone 1. However, recognize that:

  • Patients with PEF 50-69% typically need office/ED evaluation and oral corticosteroids
  • Patients with PEF 70-79% may respond to increased quick-relief medication at home
  • Consider lowering the yellow zone threshold to 80% for patients with history of severe exacerbations or poor symptom perception 4

The yellow zone should trigger increased SABA use, closer monitoring, and consideration of stepping up controller therapy, though specific yellow zone treatment strategies remain under-defined in current guidelines 2, 5, 6.

References

Research

The yellow zone in asthma treatment: is it a gray zone?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2004

Research

Empowering the child and caregiver: yellow zone Asthma Action Plan.

Current allergy and asthma reports, 2014

Research

Management of acute loss of asthma control: yellow zone strategies.

Current opinion in allergy and clinical immunology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.